Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

About This Program

This is a research funding opportunity for scientific studies utilizing expanded access data for investigational drugs or biological products targeting intermediate-sized ALS patient populations. Applicants must be eligible entities registered in SAM.gov and submit applications through Grants.gov by the posted deadline.

Key Requirements & Eligibility

• 1Must be an eligible applicant as defined in the opportunity listing
• 2SAM.gov registration required prior to application submission
• 3Application must be submitted through Grants.gov by posted deadline
• 4Research must utilize expanded access data for investigational drugs or biological products
• 5Target intermediate size populations of ALS patients